Clover Announces Corporate Updates and Full Year 2022 Financial Results
— Clover’s two premium respiratory vaccines approved in China (COVID-19 and seasonal influenza) are expected to drive meaningful and diversified…
Pharmaceuticals, Biotechnology and Life Sciences
— Clover’s two premium respiratory vaccines approved in China (COVID-19 and seasonal influenza) are expected to drive meaningful and diversified…
GreenLight’s RTP greenhouse facility in North Carolina GreenLight’s RTP greenhouse facility in North Carolina Two agriculture solutions now under regulatory…
ZKN-013 in development for treatment of recessive dystrophic epidermolysis bullosa (RDEB) and junctional epidermolysis bullosa (JEB) Additional IND filing for…
LONDON, March 28, 2023 (GLOBE NEWSWIRE) — Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical…
– Clinical data for wholly-owned anti-CTLA-4 franchise show best-in-class safety profiles for unmasked and masked candidates, unlocking the full therapeutic benefit…
BOSTON, March 28, 2023 (GLOBE NEWSWIRE) — Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing…
TORONTO, March 27, 2023 (GLOBE NEWSWIRE) — Axiom Real-Time Metrics (“Axiom”), a premier provider of unified eClinical solutions and services…
Results published in The New England Journal of Medicine and presented simultaneously at ESMO Virtual Plenary and SGO Annual Meeting72%…
WILMETTE, Ill., March 27, 2023 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing proprietary…
NEW YORK and LEAMINGTON, Ontario, March 27, 2023 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY;…